VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹1.69 Cr | ₹41 Cr | ₹42 Cr | ₹43 Cr | ₹51 Cr |
What is the latest Total Debt ratio of VENUS REMEDIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹1.69 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹51 Cr |
How is Total Debt of VENUS REMEDIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.69 Cr | -95.90 | |
| Mar2024 | ₹41 Cr | -2.29 | |
| Mar2023 | ₹42 Cr | -1.29 | |
| Mar2022 | ₹43 Cr | -16.51 | |
| Mar2021 | ₹51 Cr | - | |
Compare Total Debt of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,211.8 Cr | -4.3% | -10.9% | 204.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -4.3% |
-10.9% |
204.2% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses